These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7306965)

  • 1. Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4378-81. PubMed ID: 7306965
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity in drug sensitivity among tumor cell subpopulations of a single mammary tumor.
    Heppner GH; Dexter DL; DeNucci T; Miller FR; Calabresi P
    Cancer Res; 1978 Nov; 38(11 Pt 1):3758-63. PubMed ID: 698935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of development of methotrexate resistance in heterogeneous mouse mammary tumor cell cultures.
    Miller BE; Matherly LH; Lehotan M; Heppner GH
    J Exp Ther Oncol; 1996 Jan; 1(1):30-8. PubMed ID: 9414386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1989 Jul; 49(14):3747-53. PubMed ID: 2736515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induced resistance of experimental tumors to nitrosomethylurea].
    Krutova TV; Ostrovskaia LA
    Vopr Onkol; 1982; 28(11):48-52. PubMed ID: 7147832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement and inhibition of mammary tumor formation and growth by cytostatic drugs.
    Medina D; Shepherd F
    Cancer Res; 1977 Oct; 37(10):3571-7. PubMed ID: 908008
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth.
    Wietrzyk J; Mazurkiewicz M; Madej J; Dzimira S; Grynkiewicz G; Radzikowski C; Opolski A
    Med Sci Monit; 2004 Nov; 10(11):BR414-9. PubMed ID: 15507846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
    Orsolić N; Basić I
    Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth interaction in vivo between tumor subpopulations derived from a single mouse mammary tumor.
    Miller BE; Miller FR; Leith J; Heppner GH
    Cancer Res; 1980 Nov; 40(11):3977-81. PubMed ID: 7471048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in the growth of tumor cells injected intraperitoneally into syngeneic adult mice.
    Morrissey LW; Sidky YA; Auerbach R
    Cancer Res; 1980 Jul; 40(7):2197-201. PubMed ID: 7388788
    [No Abstract]   [Full Text] [Related]  

  • 13. Functionally sensitive and resistant populations of lymphoid cells from normal and mammary tumor bearing mice following treatment with cyclophosphamide.
    Lopez DM; Paul RD; Gadgil AU; Lichter W
    Anticancer Res; 1982; 2(4):227-33. PubMed ID: 7149652
    [No Abstract]   [Full Text] [Related]  

  • 14. Androgeno-dependent mammary tumour in A2G mice.
    Zimel H; Rivenzon A; Macrineanu A
    Neoplasma; 1968; 15(3):251-8. PubMed ID: 5667088
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biosynthesis of cobalamin coenzymes in tumor and hematopoietic tissues in assessing methotrexate sensitivity].
    Miasishcheva NV; Vares IuV; Golenko OD; Nikolaeva TG
    Vestn Akad Med Nauk SSSR; 1986; (5):36-41. PubMed ID: 3727783
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on the biologic properties, pathology and sensitivity to anticancer drugs of a new murine mammary carcinoma model (MA 782/5 S)].
    Liu SY
    Zhonghua Zhong Liu Za Zhi; 1982 May; 4(2):81-5. PubMed ID: 7128429
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental study on the establishment of a mammary adenocarcinoma MA--737 (author's transl)].
    Sun WY; Ma KS; Guan JF
    Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):168-73. PubMed ID: 7227180
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
    Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
    Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
    Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adriamycin effects and the interactions of adriamycin with X irradiation on murine mammary tumors.
    Dethlefsen LA; Riley RM
    Radiat Res; 1982 Apr; 90(1):165-72. PubMed ID: 7063633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.